Site Map
JapaneseThe information on pharmaceutical products (including products currently in development) contained in this press release is intended for the disclosure of company information and is not intended as pharmaceutical promotion or advertising or medical advice.
All Press Releases (Japanese)Sort by year
Sort by category
- R&DTopline Data from Treatment Period I in the Japanese Phase 2/3 Clinical Study of Paltusotine (SK-5307) in Patients with Acromegaly and Pituitary Gigantism
- R&DSanwa Kagaku Kenkyusho and Nissan Chemical Announceration to Co-develop SK-2407/SN-001 for DRPLA
- CompanySuzuken Group, EPS Holdings, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market